Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCDH | ISIN: US2682111099 | Ticker-Symbol: TLFP
Frankfurt
24.01.25
08:15 Uhr
0,600 Euro
0,000
0,00 %
Branche
Netzwerktechnik
Aktienmarkt
Sonstige
1-Jahres-Chart
DZS INC Chart 1 Jahr
5-Tage-Chart
DZS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,8001,00024.01.
ACCESS Newswire
245 Leser
Artikel bewerten:
(1)

DZS to Present at the Dealflow Events MicroCap Conference 2025

Finanznachrichten News

DALLAS, TX / ACCESS Newswire / January 24, 2025 / DZS (OTC PINK:DZSI), a developer of Network Edge and Connectivity systems and Cloud Edge software solutions enabling broadband everywhere, today announced that Geoff Burke, Senior Vice President of Marketing and Investor Relations, will participate and present at the Dealflow Events MicroCap Conference 2025. The conference is being held January 28-30, 2025, at the Borgata Hotel Casino & Spa in Atlantic City, N.J.

Mr. Burke will provide two presentations, one on January 29 at 5PM ET and a second on January 30 at 2PM ET and will be available for one-on-one meeting with registered investors at the conference. The presentation will be available after the conference on the Company's investor relations website at DZS Inc. - Investor Relations.

About DZS

DZS Inc. (OTC: DZSI) is a developer of Network Edge and Connectivity systems and Cloud Edge software solutions enabling broadband everywhere. A technology partner to over half of the top 25 telecom operators in the Americas, Europe, Middle East and Australia, and hundreds of fiber service providers globally, DZS systems, software and solutions empower communications service providers to deliver advanced broadband services with extraordinary agility, flexibility and performance.

DZS, the DZS logo, and all DZS product names are trademarks of DZS Inc. Other brand and product names are trademarks of their respective holders. Specifications, products, and/or product names are all subject to change.

This press release contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Private Securities Litigation Reform Act of 1995. These statements reflect the beliefs and assumptions of the Company's management as of the date hereof. Words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "plan," "project," "seek," "should," "target," "will," "would," variations of such words, and similar expressions are intended to identify forward-looking statements. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. The Company's actual results could differ materially and adversely from those expressed in or contemplated by the forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risk factors contained in the Company's SEC filings available at www.sec.gov, including without limitation, the Company's annual report on Form 10-K, quarterly reports on Form 10-Q and subsequent filings. In addition, additional or unforeseen affects from the COVID-19 pandemic and the global economic climate may give rise to or amplify many of these risks. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. DZS undertakes no obligation to update or revise any forward-looking statements for any reason.

For further information see: www.DZSi.com
DZS on Twitter: https://twitter.com/dzs_innovation
DZS on LinkedIn: https://www.linkedin.com/company/DZSi/

Press and Inquiries:
Geoff Burke
SVP Marketing & Investor Relations
Email: IR@dzsi.com

SOURCE: DZS



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.